-
1
-
-
34347360557
-
Incidente, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals
-
Bassetti M, Treacarichi EM, Righi E, et al. Incidente, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. Diag Micr infec Dis. 2007;58:325-31.
-
(2007)
Diag Micr Infec Dis
, vol.58
, pp. 325-331
-
-
Bassetti, M.1
Treacarichi, E.M.2
Righi, E.3
-
2
-
-
0029075535
-
Epidemiology of nocosomial fungal infection, with emphasis on Candida species
-
Jarvis WR. Epidemiology of nocosomial fungal infection, with emphasis on Candida species. Clin Infect Dis. 1995;20:1526-30.
-
(1995)
Clin Infect Dis
, vol.20
, pp. 1526-1530
-
-
Jarvis, W.R.1
-
3
-
-
20144388435
-
Epidemiology and predictors of mortality in cases of Candida bloodstream infection: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003
-
Almirante B, Rodríguez D, Park BJ, et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2005;43:1829-35.
-
(2005)
J Clin Microbiol
, vol.43
, pp. 1829-1835
-
-
Almirante, B.1
Rodríguez, D.2
Park, B.J.3
-
4
-
-
0036708351
-
Increasing incidence of candidemia: Results from a 20-year nationwide study in Iceland
-
Asmundsdottir LR, Erlendsdottir H, Gottfredsson M. Increasing incidence of candidemia: results from a 20-year nationwide study in Iceland. J Clin Microbiol. 2002;40:3489-92.
-
(2002)
J Clin Microbiol
, vol.40
, pp. 3489-3492
-
-
Asmundsdottir, L.R.1
Erlendsdottir, H.2
Gottfredsson, M.3
-
5
-
-
0032790231
-
High rate of non-albicans candidemia in Brazilian tertiary care hospitals
-
Colombo AL, Nucci M, Salomao R, et al. High rate of non-albicans candidemia in Brazilian tertiary care hospitals. Diagn Microbiol Infect Dis. 1999;34:281-6.
-
(1999)
Diagn Microbiol Infect Dis
, vol.34
, pp. 281-286
-
-
Colombo, A.L.1
Nucci, M.2
Salomao, R.3
-
6
-
-
0033829201
-
Nosocomial candidemia in nonneutropenic patients at an Italian tertiary care hospital
-
Luzzati R, Amalfitano G, Lazzarini L, et al. Nosocomial candidemia in nonneutropenic patients at an Italian tertiary care hospital. Eur J Clin Microbiol Infect Dis. 2000;19:602-7.
-
(2000)
Eur J Clin Microbiol Infect Dis
, vol.19
, pp. 602-607
-
-
Luzzati, R.1
Amalfitano, G.2
Lazzarini, L.3
-
7
-
-
10744222717
-
Epidemiology of candidemia in Swiss tertiary care hospitals: Secular trends, 1991-2000
-
Marchetti O, Bille J, Fluckiger U, et al. Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis. 2004;38:311-20.
-
(2004)
Clin Infect Dis
, vol.38
, pp. 311-320
-
-
Marchetti, O.1
Bille, J.2
Fluckiger, U.3
-
8
-
-
78049500483
-
Nationwide sentinel surveillance of bloodstream candida infections in 40 tertiary care hospitals in Spain
-
Cisterna R, Ezpeleta E, Telleria O. Nationwide sentinel surveillance of bloodstream candida infections in 40 tertiary care hospitals in Spain. J Clin Microbiol. 2010;48:4200-6.
-
(2010)
J Clin Microbiol
, vol.48
, pp. 4200-4206
-
-
Cisterna, R.1
Ezpeleta, E.2
Telleria, O.3
-
9
-
-
0033829201
-
Nosocomial candidemia in nonneutropenic patients at an Italian Tertiary care hospital
-
Luzzati R, Amalfitano G, Lazzarini L, et al. Nosocomial candidemia in nonneutropenic patients at an Italian Tertiary care hospital. J Clin Microbiol Infect Dis. 2000;19:602-7.
-
(2000)
J Clin Microbiol Infect Dis
, vol.19
, pp. 602-607
-
-
Luzzati, R.1
Amalfitano, G.2
Lazzarini, L.3
-
10
-
-
79955605427
-
Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: Results from the FUNGEMYCA study
-
Pemán J, Cantón E, Miñana JJ, et al. Changes in the epidemiology of fungaemia and fluconazole susceptibility of blood isolates during the last 10 years in Spain: results from the FUNGEMYCA study. Rev Iberoam Micol. 2011;28:91-9.
-
(2011)
Rev Iberoam Micol
, vol.28
, pp. 91-99
-
-
Pemán, J.1
Cantón, E.2
Miñana, J.J.3
-
11
-
-
0009080964
-
The diagnostic value of fungal surveillance cultures in critically ill patients
-
Pelz RK, Lipsett PA, Swoboda SM, et al. The diagnostic value of fungal surveillance cultures in critically ill patients. Surgical infections. 2000;1: 273-81.
-
(2000)
Surgical Infections
, vol.1
, pp. 273-281
-
-
Pelz, R.K.1
Lipsett, P.A.2
Swoboda, S.M.3
-
12
-
-
0242659142
-
Attributable mortality of nosocomial candidemia, revisited
-
Gudlaugsson O, Gillespie S, Lee K, et al. Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis. 2003;37:1172-7.
-
(2003)
Clin Infect Dis
, vol.37
, pp. 1172-1177
-
-
Gudlaugsson, O.1
Gillespie, S.2
Lee, K.3
-
14
-
-
0029058365
-
Nosocomial bloodstreams infection. Secular trends in rates, mortality, and contribution to total hospital deaths
-
Pittet D, Wenzel RP. Nosocomial bloodstreams infection. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med. 1995;155:1177-84.
-
(1995)
Arch Intern Med
, vol.155
, pp. 1177-1184
-
-
Pittet, D.1
Wenzel, R.P.2
-
15
-
-
0345340404
-
The changing face of candidemia: Emergence of non-Candida albicans species and antifungal resistance
-
Nguyen MH, Peacock JE, Morris AJ, et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med. 1996;100:617-23.
-
(1996)
Am J Med
, vol.100
, pp. 617-623
-
-
Nguyen, M.H.1
Peacock, J.E.2
Morris, A.J.3
-
16
-
-
33644506461
-
Epidemiological trends in nosocomial candidemia in intensive care
-
Bassetti M, Righi E, Costa A, et al. Epidemiological trends in nosocomial candidemia in intensive care. BCM Infect Dis. 2006;10:21.
-
(2006)
BCM Infect Dis
, vol.10
, pp. 21
-
-
Bassetti, M.1
Righi, E.2
Costa, A.3
-
17
-
-
0036720774
-
Secular trend of hospital-acquired candidemia among intensive care unit patients in the united States during 1989-99
-
Trick WE, Fridkin SK, Edwards JR, et al. Secular trend of hospital-acquired candidemia among intensive care unit patients in the united States during 1989-99. Clin Infect Dis. 2002;35:627-30.
-
(2002)
Clin Infect Dis
, vol.35
, pp. 627-630
-
-
Trick, W.E.1
Fridkin, S.K.2
Edwards, J.R.3
-
18
-
-
17144466471
-
Secular trends in nosocomial primary bloodstream infections in the United States
-
Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States. Am J Med. 1991;91: 86-9.
-
(1991)
Am J Med
, vol.91
, pp. 86-89
-
-
Banerjee, S.N.1
Emori, T.G.2
Culver, D.H.3
-
19
-
-
0027511893
-
Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-90
-
Beck-Sague CM, Jarvis W. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-90. J Infect Dis. 1993;167: 1247-51.
-
(1993)
J Infect Dis
, vol.167
, pp. 1247-1251
-
-
Beck-Sague, C.M.1
Jarvis, W.2
-
20
-
-
10744222717
-
Epidemiology of candidemia in swiss teriary care hospitals: Secular trends, 1991-2000
-
Marchetti O, Billie J, Fluckiger U, et al. Epidemiology of candidemia in swiss teriary care hospitals: secular trends, 1991-2000. Clin Infect Dis. 2004;38: 311-20.
-
(2004)
Clin Infect Dis
, vol.38
, pp. 311-320
-
-
Marchetti, O.1
Billie, J.2
Fluckiger, U.3
-
21
-
-
0034834774
-
International surveillance of bloodstream infection due to Candida species: Frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole and voriconazole of isolates collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program
-
Pfaller MA, Diekema DJ, Jones RN, et al. International surveillance of bloodstream infection due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole and voriconazole of isolates collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program. J Clin Microbiol. 2001;39:3254-9.
-
(2001)
J Clin Microbiol
, vol.39
, pp. 3254-3259
-
-
Pfaller, M.A.1
Diekema, D.J.2
Jones, R.N.3
-
22
-
-
50949116280
-
Association of fluconazole pharmacodynamics with mortality in patients with candidemia
-
Baddley JW, Patel M, Bhavnani SM, et al. association of fluconazole pharmacodynamics with mortality in patients with candidemia. Antimicrob Agents Chemother. 2008;52:3022-8.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 3022-3028
-
-
Baddley, J.W.1
Patel, M.2
Bhavnani, S.M.3
-
24
-
-
0026534498
-
In vitro susceptibility of yeast isolates from the blood to fluconazole and amphotericin B
-
Dermoumi H. In vitro susceptibility of yeast isolates from the blood to fluconazole and amphotericin B. Chemotherapy. 1992;38:112-7.
-
(1992)
Chemotherapy
, vol.38
, pp. 112-117
-
-
Dermoumi, H.1
-
25
-
-
0024418245
-
Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei
-
Fisher MA, Shen SH, Haddad J, Tarry WF. Comparison of in vivo activity of fluconazole with that of amphotericin B against Candida tropicalis, Candida glabrata, and Candida krusei. Antimicrob Agents Chemother. 1989;33: 1443-6.
-
(1989)
Antimicrob Agents Chemother
, vol.33
, pp. 1443-1446
-
-
Fisher, M.A.1
Shen, S.H.2
Haddad, J.3
Tarry, W.F.4
-
26
-
-
0034075720
-
Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750
-
Barchiesi F, Calabrese D, Sanglard D. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750. Antimicrob Agents Chemother. 2000;44:1578-84.
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 1578-1584
-
-
Barchiesi, F.1
Calabrese, D.2
Sanglard, D.3
-
28
-
-
79953214056
-
In vitro activity of echinocandins against noncandida albicans: Is echinocandin antifungal activity the same?
-
Espinel-Ingroff A, Canton E. In vitro activity of echinocandins against noncandida albicans: is echinocandin antifungal activity the same? Enferm Infec Microbiol Clin. 2011;29:3-9.
-
(2011)
Enferm Infec Microbiol Clin
, vol.29
, pp. 3-9
-
-
Espinel-Ingroff, A.1
Canton, E.2
-
29
-
-
53149145998
-
Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: Analysis and proposal for interpretive MIC breakpoints
-
Pfaller MA, Diekema DJ, Ostrosky-Zeichner L, et al. Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol. 2008;46:2620-9.
-
(2008)
J Clin Microbiol
, vol.46
, pp. 2620-2629
-
-
Pfaller, M.A.1
Diekema, D.J.2
Ostrosky-Zeichner, L.3
-
31
-
-
0037137576
-
Comparison of caspofungin and amphotericin B for invasive candidiasis
-
Mora-Duarte J, Betts R, Rotstein C, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med. 2002;347:2020-9.
-
(2002)
N Engl J Med
, vol.347
, pp. 2020-2029
-
-
Mora-Duarte, J.1
Betts, R.2
Rotstein, C.3
-
32
-
-
27744463412
-
Anidulafungin: A new echinocandin with a novel profile
-
Vazquez JA. Anidulafungin: a new echinocandin with a novel profile. Clin Ther. 2005;27:657-73.
-
(2005)
Clin Ther
, vol.27
, pp. 657-673
-
-
Vazquez, J.A.1
-
33
-
-
23844465659
-
Echinocandins: Role in antifungal therapy, 2005
-
Zaas AK, Alexander BD. Echinocandins: role in antifungal therapy, 2005. Exp Opin Pharmacother. 2005;6:1657-68.
-
(2005)
Exp Opin Pharmacother
, vol.6
, pp. 1657-1668
-
-
Zaas, A.K.1
Alexander, B.D.2
-
34
-
-
79959193758
-
Clinical breakpoints for voriconazole and Candida spp. revisited: Review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria
-
Pfaller MA, Andes D, Arendrup MC, et al. Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria. Diagn Microbiol Infect Dis. 2011;70: 330-43.
-
(2011)
Diagn Microbiol Infect Dis
, vol.70
, pp. 330-343
-
-
Pfaller, M.A.1
Andes, D.2
Arendrup, M.C.3
-
35
-
-
79952347827
-
Comparison of the Broth Microdilution (BMD) Method of the European Committee on Antimicrobial Susceptibility Testing with the 24-Hour CLSI BMD Method for Testing Susceptibility of Candida Species to Fluconazole, Posaconazole, and Voriconazole by Use of Epidemiological Cutoff Values
-
Pfaller MA, Espinel-Ingroff A, Boyken L, et al. Comparison of the Broth Microdilution (BMD) Method of the European Committee on Antimicrobial Susceptibility Testing with the 24-Hour CLSI BMD Method for Testing Susceptibility of Candida Species to Fluconazole, Posaconazole, and Voriconazole by Use of Epidemiological Cutoff Values. J Clin Microbiol. 2011; 49:845-50.
-
(2011)
J Clin Microbiol
, vol.49
, pp. 845-850
-
-
Pfaller, M.A.1
Espinel-Ingroff, A.2
Boyken, L.3
-
36
-
-
84898693920
-
-
CLSI Antifungal Subcommittee
-
CLSI Antifungal Subcommittee. Current breakpoints and epidemiological cut-off values for molds 2011; http://www.clsi.org/Content/NavigationMenu/Committees/Microbiology/SCAntifungalSusceptibilityTesting/January2010AntifungalSusceptibilityMeetingPresentations/4f_MPfaller_YeastsBPS_MouldsECVs_Table_20110419.pdf.
-
Current Breakpoints and Epidemiological Cut-off Values For Molds 2011
-
-
-
37
-
-
84857877569
-
-
Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, Third Edition, Clinical Laboratory Standards Institute, Wayne, PA
-
Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard, Third Edition. Document M27-A3. Clinical Laboratory Standards Institute, Wayne, PA; 2008.
-
(2008)
Document M27-A3
-
-
-
38
-
-
73949126140
-
Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp
-
Pfaller MA, Boyden L, Hollis RJ, et al. Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. J Clin Microbiol. 2010;48:52-6.
-
(2010)
J Clin Microbiol
, vol.48
, pp. 52-56
-
-
Pfaller, M.A.1
Boyden, L.2
Hollis, R.J.3
-
39
-
-
79955538785
-
Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
-
Pfaller MA, Diekema DJ, Andes D, et al. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria. Drug Resist Updat. 2011;14:164-76.
-
(2011)
Drug Resist Updat
, vol.14
, pp. 164-176
-
-
Pfaller, M.A.1
Diekema, D.J.2
Andes, D.3
|